Weight-Loss Drug Zepbound May Lower Heart Failure Deaths
THURSDAY, Nov. 21, 2024 (HealthDay News) — A drug used to help patients lose weight and manage diabetes may also help those with heart failure, an international clinical trial shows. The test of tirzepatide, brand named Zepbound, included 731 patients with diastolic heart failure and obesity who were followed forContinue Reading